1. Home
  2. RZLV vs VIR Comparison

RZLV vs VIR Comparison

Compare RZLV & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLV
  • VIR
  • Stock Information
  • Founded
  • RZLV 2016
  • VIR 2016
  • Country
  • RZLV United Kingdom
  • VIR United States
  • Employees
  • RZLV N/A
  • VIR N/A
  • Industry
  • RZLV
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • RZLV
  • VIR Health Care
  • Exchange
  • RZLV NYSE
  • VIR Nasdaq
  • Market Cap
  • RZLV 979.0M
  • VIR 1.0B
  • IPO Year
  • RZLV N/A
  • VIR 2019
  • Fundamental
  • Price
  • RZLV $4.50
  • VIR $9.26
  • Analyst Decision
  • RZLV
  • VIR Buy
  • Analyst Count
  • RZLV 0
  • VIR 5
  • Target Price
  • RZLV N/A
  • VIR $36.80
  • AVG Volume (30 Days)
  • RZLV 184.3K
  • VIR 1.0M
  • Earning Date
  • RZLV 11-21-2024
  • VIR 10-31-2024
  • Dividend Yield
  • RZLV N/A
  • VIR N/A
  • EPS Growth
  • RZLV N/A
  • VIR N/A
  • EPS
  • RZLV N/A
  • VIR N/A
  • Revenue
  • RZLV $145,051.00
  • VIR $78,618,000.00
  • Revenue This Year
  • RZLV N/A
  • VIR N/A
  • Revenue Next Year
  • RZLV N/A
  • VIR N/A
  • P/E Ratio
  • RZLV N/A
  • VIR N/A
  • Revenue Growth
  • RZLV 25.96
  • VIR N/A
  • 52 Week Low
  • RZLV $4.49
  • VIR $7.12
  • 52 Week High
  • RZLV $14.50
  • VIR $13.09
  • Technical
  • Relative Strength Index (RSI)
  • RZLV N/A
  • VIR 73.49
  • Support Level
  • RZLV N/A
  • VIR $7.24
  • Resistance Level
  • RZLV N/A
  • VIR $7.82
  • Average True Range (ATR)
  • RZLV 0.00
  • VIR 0.43
  • MACD
  • RZLV 0.00
  • VIR 0.12
  • Stochastic Oscillator
  • RZLV 0.00
  • VIR 81.85

About RZLV REZOLVE AI LTD

Rezolve AI Ltd provides a mobile commerce and engagement platform, underpinned by machine learning, that enables retailers, brands and manufacturers to engage with consumers in a broad range of locations and settings via their mobile devices and personal computers. its platform allows for mobile engagement with merchants using its software to extend their business to consumers' mobile devices and computers in different ways.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: